Future of Molecular Diagnostics Market Highlighting Regional Revenue Share Dominance by 2031
Molecular Diagnostics Market by Product & Services [Systems & Instruments, Assay Reagents & Kits, and Software & Service], Technology [Polymerase Chain Reaction (PCR), DNA Sequencing & Next-Generation Sequencing (NGS), In Situ Hybridization, and Microarrays], Application [Infectious disease, Oncology, Pharmacogenomics, Genetic Testing], End User [Hospitals, Academic Institutes & Research Centers and Clinical & Pathology Labs] – Global Outlook & Forecast 2021-2031.
According to the deep-dive market assessment study conducted by Growth+ Reports, the global molecular diagnostics market was pegged at ~US$ 9.1 billion in 2020. The market is expected to witness a CAGR of ~8.6% from 2021 to 2031.
The prevalence of chronic diseases, infectious diseases, and genetic disorders has also increased significantly. Molecular diagnostics are widely used for the detection of these diseases. Furthermore, sudden viral outbreaks of H1N1 & COVID-19 and an increase in its incidence across the globe have raised the demand for effective diagnostic technologies. The first case of COVID-19 was found in Dec 2019, by the end of Dec 2020, the count has surged to more than 90.3 million globally. This factor is expected to boost the growth of the market considerably. In an effort to maintain their position in market, prominent players are continuously launching several novel or complementary diagnostic methods.
To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/molecular-diagnostics-market/7674
The report includes an in-depth study of the global market Molecular Diagnostics, where segments and sub-segments are analysed in quite a detail. This research will help players focus on high-growth segments and modify their business strategies if needed. The Diabetes Care Devices global market is segmented based on Products, Technology, and End Users. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, Europe, Asia Pacific, and the Rest of the World (RoW). Our researchers and analysts use reliable primary and secondary sources for research and data.
Some of the prominent players operating in the global Molecular Diagnostics Market include
Ø F. Hoffmann-La Roche Ltd
Ø bioMerieux SA
Ø Beckman Coulter
Ø BD, Siemens Healthcare Private Limited
Ø Grifols
Ø S.A
Ø Abbott Laboratories
Ø Hologic
Ø Danaher
Ø QIAGEN
